I am/have/had
I am looking for
Advanced Filters
Found 12 clinical trials
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer
This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).
measurable disease
prostatic neoplasms, castration-resistant
cancer
combined modality therapy
testosterone
- 0 views
- 19 Feb, 2024
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
This phase II study investigates how well radium-223 works in treating patients with castration-resistant prostate cancer than has spread to the bones (bone metastases). Prostate cancer is the most common cancer in men and the second leading cause of cancer death.
metastatic hormone refractory prostate cancer
metastatic prostate cancer
bone metastases
testosterone
stage iv prostate cancer ajcc v8
- 0 views
- 19 Feb, 2024
- 1
- 2